Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021.

MLA

Seppälä, Elina, et al. “Vaccine Effectiveness against Infection with the Delta (B.1.617.2) Variant, Norway, April to August 2021.” Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, vol. 26, no. 35, Sept. 2021. EBSCOhost, https://doi.org/10.2807/1560-7917.ES.2021.26.35.2100793.

APA

Seppälä, E., Veneti, L., Starrfelt, J., Danielsen, A. S., Bragstad, K., Hungnes, O., Taxt, A. M., Watle, S. V., & Meijerink, H. (2021). Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021. Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 26(35). https://doi.org/10.2807/1560-7917.ES.2021.26.35.2100793

Chicago

Seppälä, Elina, Lamprini Veneti, Jostein Starrfelt, Anders Skyrud Danielsen, Karoline Bragstad, Olav Hungnes, Arne Michael Taxt, Sara Viksmoen Watle, and Hinta Meijerink. 2021. “Vaccine Effectiveness against Infection with the Delta (B.1.617.2) Variant, Norway, April to August 2021.” Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 26 (35). doi:10.2807/1560-7917.ES.2021.26.35.2100793.